Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Keila, S.
Right arrow Articles by Weinreb, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keila, S.
Right arrow Articles by Weinreb, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In vitro Effects of Enamel Matrix Proteins on Rat Bone Marrow Cells and Gingival Fibroblasts

S. Keila1, C.E. Nemcovsky2, O. Moses2, Z. Artzi2 and M. Weinreb1,*

1 Departments of Oral Biology and
2 Periodontology, The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv 69978, Israel;


Figure 1
View larger version (46K):
[in this window]
[in a new window]

 
Figure 1. Nodule formation by BMSC. (A) Representative wells stained with the Von-Kossa method showing more mineralized nodules in cultures treated with Emdogain (EMD) at 25 µg/mL. (B) Quantitation of the number of nodules/well (mean ± SE, N = 6/group). Only EMD at 25 µg/mL increased nodule number. ***P < 0.005 (EMD at 25 µg/mL vs. control or 100 µg/mL). (C) Quantitation of the dish area covered with mineralized nodules (mean ± SE, N = 6/group). Only EMD at 25 µg/mL increased nodule area. ***P < 0.005 (EMD at 25 µg/mL vs. control or 100 µg/mL).

 

Figure 2
View larger version (20K):
[in this window]
[in a new window]

 
Figure 2. (A) Alkaline phosphatase (ALP) activity of BMSC is enhanced by Emdogain (EMD) at 25 µg/mL (mean ± SE, N = 6/group). **P < 0.01 (EMD vs. control). (B) Quantitation of the number of nodules/well (mean ± SE, N = 6/group). EMD (25 µg/mL) was added immediately upon seeding (Time 0) or 48 hrs later, after removal of non-adherent cells. Only EMD at time 0 increased nodule formation. ***P < 0.005 (EMD at Time 0 vs. control or EMD at 48 hrs). (C) EMD (25 µg/mL) increases the number of adherent BMSC at 48 hrs (mean ± SE, N = 6/group). ***P < 0.005 (EMD vs. control). (D) EMD (25 µg/mL) increases the protein content of BMSC cultures on day 10 (mean ± SE, N = 6/group). *P < 0.05 (EMD vs. control).

 

Figure 3
View larger version (40K):
[in this window]
[in a new window]

 
Figure 3. GF cultures. (A) Representative wells after Von-Kossa staining showing no mineralization but darker color of the matrix, with a greater effect of Emdogain (EMD) at 100 µg/mL than at 25 µg/mL. (B) Average optical density in arbitrary units of the GF matrix. Since darker color is associated with lower OD values (255 = white, 0 = black), the matrix of GF cells treated with EMD stains more intensely (mean ± SE, N = 6/group). ***P < 0.005 vs. control. (C) The protein content of GF cultures increases with the EMD concentration (mean ± SE, N = 6/group). *P < 0.05, ***P < 0.005 (vs. control).

 

Figure 4
View larger version (12K):
[in this window]
[in a new window]

 
Figure 4. Emdogain (EMD, 100 µg/mL) increases GF cell number, determined on days 2, 5, or 12 (mean ± SE, N = 6/group). *P < 0.05; **P < 0.01; ***P < 0.005 (vs. the respective control).

 

Journal of Dental Research, Vol. 83, No. 2, 134-138 (2004)
DOI: 10.1177/154405910408300210


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?